All Online

13 - 17 of 17 results


Active filters

Diabetes Mellitus, Type 2

Cardiovascular Risk in T2DM: Why Does It Matter? (Part 1 of 3)

0.25 CME/MOC
0.25 AANP | 0.08 Pharmacology |

During this session (part 1 of 3 webcast videos), Dr. Tina Thethi reviews the association between type 2 diabetes and cardiovascular disease as well as provides an overview of the American Diabetes Association guidelines designed to help individualize therapy for patients with T2DM and concurrent heart failure and/or atherosclerotic cardiovascular disease. *Please note that any data, indications and guidelines presented in this activity are current as of the original recording on 12/3/2019, and they are subject to change as new information is published.


This talk will cover recent clinical trials presented at the ADA in 2019 that have an impact on the management of diabetes, such as cardiovascular outcomes trials and the first oral GLP-1 RA phase 3 data. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. After this meeting review, you will be equipped to manage type 2 diabetes based on these guidelines.


The incidence and prevalence of prediabetes and Type II Diabetes Mellitus in adolescents and young adults has increased over the past decade. A recent cross-sectional study of 12 years of NHANES data suggests that this population has an associated increased cardiometabolic risk. Listen as our team discusses these findings and some prevention strategies to help improve health outcomes.


Join us as we discuss key points from the 2019 update to the American Diabetes Association and the European Association for the Study of Diabetes consensus report. This update is now reflected in the American Diabetes Association's Standards of Medical Care—2020.


Primary care clinicians (PCCs) are ideally suited to educate and advise people with type 2 diabetes about basal insulin. This program will inform PCCs about current recommendations and advances in the safe and effective use of basal insulin, so they can provide individualized, appropriate care for their patients.